2019 - 2022 Anti-tumor effect of Galectin-9 on metastatic hepatocellular carcinoma and its microRNA basis
2019 - 2021 Antitumor effect of HCC and exosome microRNA by angiotensin II receptor blockers and molecular target drugs
Papers (87)：
Kyoko Oura, Asahiro Morishita, Rie Yano, Takushi Manabe, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, et al. Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma. Journal of gastroenterology. 2025
Takushi Manabe, Chikara Ogawa, Takashi Tamada, Naoki Yoshioka, Takehiro Akahane, Hideki Fujii, Hirotaka Arai, Kei Takuma, Mai Nakahara, Kyoko Oura, et al. Usefulness of Repeated Lusutrombopag Administration in Clinical Practice and its Correlation with the Simulation Software-Predicted Platelet Count: A Multicenter Study. Internal medicine (Tokyo, Japan). 2025
Koji Fujita, Kei Takuma, Kyoko Oura, Tomoko Tadokoro, Asahiro Morishita, Takashi Himoto, Hideki Kobara. Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for Hydration. Clinical and translational science. 2025. 18. 3. e70182
Shima Mimura, Asahiro Morishita, Kyoko Oura, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Hideki Kobara. Galectins and Liver Diseases. International journal of molecular sciences. 2025. 26. 2
Tomoko Tadokoro, Joji Tani, Yudai Sato, Rie Yano, Kei Takuma, Mai Nakahara, Kyoko Oura, Koji Fujita, Masafumi Ono, Atsushi Tobiume, et al. Decompensated Cirrhosis with Hepatopulmonary Syndrome in a Patient with Interrupted Treatment for Hypopituitarism: A Case Report. Internal medicine (Tokyo, Japan). 2025
